PharmacoDB

Home/
Explore/

Explore PharmacoDB!

Step 2: select cell line / drug

tissues

drugs

S-Trityl-L-cysteine

AKT inhibitor VIII

Genentech Cpd 10

Obatoclax Mesylate

Ispinesib Mesylate

JNK Inhibitor VIII

(5Z)-7-Oxozeaenol

Bax channel blocker

isoliquiritigenin

trifluoperazine

epigallocatechin-3-monogallate

Cyclophosphamide

prochlorperazine

pyrazolanthrone

N9-isopropylolomoucine

pifithrin-alpha

GSK-3 inhibitor IX

triazolothiadiazine

16-beta-bromoandrosterone

PRL-3 Inhibitor I

Compound 7d-cis

cyanoquinoline 11

Compound 23 citrate

JQ-1:UNC0638 (2:1 mol/mol)

carboplatin:UNC0638 (2:1 mol/mol)

vorinostat:carboplatin (1:1 mol/mol)

serdemetan:SCH-529074 (1:1 mol/mol)

selumetinib:PLX-4032 (8:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

navitoclax:birinapant (1:1 mol/mol)

ISOX:bortezomib (250:1 mol/mol)

selumetinib:GDC-0941 (4:1 mol/mol)

selumetinib:tretinoin (2:1 mol/mol)

selumetinib:vorinostat (8:1 mol/mol)

selumetinib:JQ-1 (4:1 mol/mol)

selumetinib:BRD-A02303741 (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

tretinoin:carboplatin (2:1 mol/mol)

tanespimycin:gemcitabine (1:1 mol/mol)

docetaxel:tanespimycin (2:1 mol/mol)

selumetinib:MK-2206 (8:1 mol/mol)

navitoclax:PLX-4032 (1:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

navitoclax:MST-312 (1:1 mol/mol)

carboplatin:etoposide (40:17 mol/mol)

piperlongumine:MST-312 (1:1 mol/mol)

navitoclax:gemcitabine (1:1 mol/mol)

navitoclax:pluripotin (1:1 mol/mol)

JQ-1:carboplatin (1:1 mol/mol)

selumetinib:navitoclax (8:1 mol/mol)

selumetinib:decitabine (4:1 mol/mol)

decitabine:carboplatin (1:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

JQ-1:navitoclax (2:1 mol/mol)

JQ-1:MK-0752 (1:1 mol/mol)

BRD-A02303741:navitoclax (2:1 mol/mol)

salermide:PLX-4032 (12:1 mol/mol)

UNC0638:navitoclax (1:1 mol/mol)

BRD-A02303741:carboplatin (1:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

selumetinib:UNC0638 (4:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

vorinostat:navitoclax (4:1 mol/mol)

bardoxolone methyl

erlotinib:PLX-4032 (2:1 mol/mol)

JQ-1:vorinostat (2:1 mol/mol)

crizotinib:PLX-4032 (2:1 mol/mol)

BRD-K27188169:navitoclax (2:1 mol/mol)

omacetaxine mepesuccinate

avrainvillamide

isonicotinohydroxamic acid

marinopyrrole A

necrosulfonamide

ML334 diastereomer

O-6-benzylguanine

PF-4800567 hydrochloride

BRD9876:MK-1775 (4:1 mol/mol)

targets